Profile
EKSO ISRG BDXA BDX ALC RMD
Company Name Ekso Bionics Holdings, Inc. Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company Alcon Inc. ResMed Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $9.48M $183.74B $53.11B $49.57B $44.11B $40.72B
Employees 0.06K 15.64K 0.00K 70.00K 25.60K 9.98K
CEO Scott G. Davis Gary S. Guthart - Thomas E. Polen Jr. David J. Endicott Michael J. Farrell BE, MBA, SM
Ratings
EKSO ISRG BDXA BDX ALC RMD
Quant Rating Score 2 3 5 3 3 4
Quant Rating Sell Neutral Strong Buy Neutral Neutral Buy
Trading
EKSO ISRG BDXA BDX ALC RMD
Last Close $3.49 $483.12 $59.24 $176.37 $87.87 $279.2
High 52 $4.82 $610.45 $59.24 $249.08 $100.76 $279.2
Low 52 $0.25 $438 $59.24 $165.15 $82.73 $204.58
Price vs. 52 Week High -27.59 % -20.86 % 0 % -29.19 % -12.79 % 0 %
Price vs. 52 Week Low 1296 % 10.3 % 0 % 6.79 % 6.21 % 36.47 %
Total Return
EKSO ISRG BDXA BDX ALC RMD
1 Month Return 0 % -10.65 % 0 % -0.51 % -1.6 % 9.09 %
3 Month Return 622.57 % -8.75 % 0 % 4.5 % -10.61 % 16.36 %
6 Month Return 548.22 % -15.52 % 0 % -28.77 % -3.53 % 18.21 %
9 Month Return 293.42 % -4.59 % 0 % -25.03 % -4.27 % 14.3 %
YTD Return 472.13 % -7.44 % 0 % -22.26 % 3.51 % 22.09 %
1 Year Return 249 % 7.42 % 0 % -27.08 % -4.88 % 24.84 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
EKSO ISRG BDXA BDX ALC RMD
Dividend Yield Percentage (TTM) - - 2.28 % 2.35 % 0.37 % 0.76 %
Dividend Paid and Capex Coverage Ration (TTM) -35.76 % 2.77 % 1.77 % 1.77 % 3.43 % 4.21 %
Dividend Per Share (TTM) - - 4.07 % 4.07 % 0.33 % 2.12 %
Payout Ratio (TTM) -2.04 % - 76.77 % 76.77 % 11.23 % 23.14 %
Growth
EKSO ISRG BDXA BDX ALC RMD
Asset Growth -7.84 % 21.38 % 8.54 % 8.54 % 1.79 %
Gross Profit Growth 4.76 % 19.13 % 11.69 % 11.69 % 12.72 %
Revenue Growth -1.94 % 17.24 % 4.16 % 4.16 % 10.95 %
Revenue 3 Year -3.6 % 46.64 % -0.51 % -0.51 % 44.86 %
Revenue 5 Year -69.37 % 81.77 % 8.72 % 8.72 % 74.97 %
Revenue 10 Year -83.88 % 266.32 % 59.37 % 59.37 % 189.94 %
EBIT Growth 25.75 % 32.95 % 19.82 % 19.82 % 12.75 %
Net Income Growth 25.45 % 29.18 % 14.89 % 14.89 % 13.75 %
Net Income 3 Yeari Growth Per Share 18.74 % 36.6 % -18.63 % -18.63 % 112.66 %
Net Income 5 Yeari Growth Per Share 76.96 % 64.12 % 30.19 % 30.19 % 145.63 %
Net Income 10 Yeari Growth Per Share 98.39 % 418.52 % -4.02 % -4.02 % 184.54 %
Operating Income Growth 30.78 % 32.95 % 13.55 % 13.55 % 16.61 %
Operating Cash Flow Growth (CFG) 18.32 % 33.15 % 27.07 % 27.07 % 102.11 %
Operating 3 Year CFG 46.62 % 15.88 % -18.4 % -18.4 % 87.99 %
Operating 5 Year CFG 85.16 % 47.28 % 6.25 % 6.25 % 197.13 %
Operating 10 Year CFG 96.86 % 239.49 % 45.28 % 45.28 % 244.62 %
EPS Growth 49.09 % 27.71 % 18.31 % 18.31 % 13.4 %
EPS Diluted Growth 49.09 % 27.63 % 18.62 % 18.62 % 13.63 %
Book Value Per Share -30.67 % 21.99 % -0.85 % -0.85 % 17.57 %
Share Holder 3 Year Equity Growth Per Share -79.35 % 37.85 % 9.16 % 9.16 % 66.6 %
Share Holder 5 Year Equity Growth Per Share -55.55 % 93.34 % 13.89 % 13.89 % 128.49 %
Share Holder 10 Year Equity Growth Per Share -97.33 % 354.67 % 241.78 % 241.78 % 166.2 %
Dividend Per Share Growth - - -2.44 % -2.44 % 9.12 %
Dividend 3 Year Growth Per Share - - 4.79 % 4.79 % 23.08 %
Dividend 5 Year Growth Per Share - - 4.14 % 4.14 % 29.8 %
Dividend 10 Year Growth Per Share - - 74.3 % 74.3 % 91.97 %
Debt Growth -16.53 % - 26.65 % 26.65 % -44.68 %
Free Cash Flow Growth 19.06 % 73.93 % 45.25 % 45.25 % 130 %
Updated On 31 Dec 2024 31 Dec 2024 30 Sep 2024 30 Sep 2024 30 Jun 2024
Profitability
EKSO ISRG BDXA BDX ALC RMD
Gross Profit Margin TTM 51.52 % 67.09 % 44.5 % 44.5 % 55.55 % 58.53 %
Return on Assets TTM -47.85 % 12.88 % 2.75 % 2.75 % 3.61 % 17.36 %
Return on Equity TTM -86.6 % 15.52 % 5.86 % 5.86 % 5.22 % 25.18 %
Return on Capital Employed TTM -74.66 % 13.9 % 5.05 % 5.05 % 5.26 % 24.33 %
Net Income Per EBT TTM 100 % 88.31 % 89.01 % 89.01 % 83.9 % 83.26 %
EBT Per Ebit TTM 90.24 % 114.09 % 71.19 % 71.19 % 88.24 % 97.84 %
EBIT Per Revenue TTM -83.84 % 28.2 % 11.33 % 11.33 % 15.24 % 32.1 %
Cash Flow To Debt Ratio TTM -169.15 % - 17.12 % 17.12 % 40.46 % 196.83 %
Receivables Turnover TTM 3.23 6.46 6.89 6.89 5.34 5.53
Payables Turnover TTM 4.91 10.39 - - 5.24 9.36
Inventory Turnover TTM 1.31 1.85 3.11 3.11 1.88 2.41
Fixed Asset Turnover TTM 676.72 % 181.6 % 313.98 % 313.98 % 202.43 % 729.93 %
Asset Turnover TTM 63.24 % 45.34 % 38.31 % 38.31 % 32.01 % 66.36 %
Operating Cash Flow Per Share TTM -4.18 7.64 11.44 11.44 4.24 11.27
Free Cash Flow Per Share TTM -4.2 4.88 8.98 8.98 3.26 10.66
Cash Per Share TTM - 1261.9 % 236.81 % 236.81 % 285.19 % 635.71 %
Operating Cash Flow Sales Ratio TTM -62.24 % 31.34 % 15.81 % 15.81 % 21.17 % 32.92 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.32 % 63.9 % 78.51 % 78.51 % 76.82 % 94.64 %
Cash Flow Coverage Ratios TTM -169.15 % - 17.12 % 17.12 % 40.46 % 196.83 %
Price To Free Cash Flows Ratio TTM -1.04 105.28 19.72 19.14 27.32 26.03
Price To Operating Cash Flows Ratio TTM -0.87 67.1 15.58 15.12 21.01 24.65
Price Cash Flow Ratio TTM -0.87 67.1 15.58 15.12 21.01 24.65
Income Statement (TTM)
EKSO ISRG BDXA BDX ALC RMD
Revenue $0.02B $8.35B $20.18B $20.18B $9.91B $5.15B
Gross Profit $0.01B $5.63B $9.13B $9.13B $5.51B $3.05B
Gross Profit Ratio 53.06% 67.46% 45.22% 45.22% 55.61% 59.36%
EBITDA $-0.01B $2.81B $4.82B $4.82B $2.68B $1.69B
Net Income $-0.01B $2.32B $1.71B $1.71B $1.02B $1.4B
EPS Diluted -0.56 6.42 5.86 5.86 2.05 -
Balance Sheet (MRQ)
EKSO ISRG BDXA BDX ALC RMD
Long Term Debt $0B $0.11B $17.94B $17.94B $4.97B $0.84B
Total Liabilities $0.01B $2.31B $31.4B $31.4B $8.79B $2.01B
Total Equity $0.01B $16.53B $25.89B $25.89B $21.55B $4.86B
Total Investments $0B $7.05B $0.45B $0.45B $0.91B $0.17B
Total Debt $0.01B $0.15B $20.11B $20.11B $5.14B $0.87B
Total Assets $0.03B $18.84B $57.29B $57.29B $30.35B $6.87B
Cash Flow Statement (TTM)
EKSO ISRG BDXA BDX ALC RMD
Net Income $-0.01B $2.34B $1.71B $1.71B $1.02B $1.4B
Inventory $0B $-0.83B $0.1B $0.1B $-0.05B $-0.08B
Dividends Paid $0B $0B $-1.1B $-1.1B $-0.13B $-0.31B
Operating Cash Flow $-0.01B $2.42B $3.8B $3.8B $2.08B $1.75B
Capital Expenditure $0B $-1.11B $-0.73B $-0.73B $-0.67B $-0.09B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.29
ALC Alcon Inc. 87.87
ANGO AngioDynamics, Inc. 8.56
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 141.35
ATRC AtriCure, Inc. 34.41
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AZTA Azenta, Inc. 32.34
BAX Baxter International Inc. 21.96
BDX Becton, Dickinson and Company 176.37
BDXA Becton, Dickinson and Company 59.24
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 13.5
BLFS BioLife Solutions, Inc. 20.805
COO The Cooper Companies, Inc. 70.87
DXR Daxor Corporation 9.45
FEMY Femasys Inc. 0.8196
GCTK GlucoTrack, Inc. 6.23
ETFs With Exposure to EKSO
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 305.74
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 135.8
VXF Vanguard Extended Market Index Fund 0.00003 193.64
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 104.02
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 104
DFUS Dimensional U.S. Equity ETF 0.0000235 67.41
DFAC Dimensional U.S. Core Equity 2 ETF 0.00000288 36.05
VTSAX Vanguard Total Stock Market Index Fund 0 148.89
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00003 146.9
VITSX Vanguard Total Stock Market Index Fund 0 148.91
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00003 146.91
VEMPX Vanguard Extended Market Index InstlPlus 0.00003 362.53
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 279.34
Unlock